Compare Iris Energy Limited (IREN) vs Medtronic PLC (MDT) Price & Performance

IREN stock trades at $43.67, up 9.86% in the past 24 hours, reflecting strong momentum driven by recent AI infrastructure milestones. The company reported revenue of $501 million in 2025, with a net income margin of 20.88%, though it missed Q1 2026 EPS estimates. Technical indicators show a bullish trend with support at $42 and resistance at $45. Recent news highlights the delivery of Horizon 1 to Microsoft and NVIDIA Exemplar Cloud status, boosting investor confidence.

The outlook for IREN is positive due to its pivot to AI data centers and $4 billion annualized revenue target, but risks include execution challenges and high valuation multiples. Analysts are largely bullish with a consensus price target of $84.43, suggesting significant upside if growth targets are met.

Medtronic (MDT) trades at $90.58, showing modest daily decline of -0.11% but maintaining strong technical momentum with bullish moving averages. The company demonstrates solid fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.55 beating expectations of $1.54, and robust profitability with 65.02% gross margins. Recent product innovations include FDA clearance for AI surgical platform and expanded CE Mark for cardiac ablation systems, positioning MDT for continued medical technology leadership.

MDT presents a compelling investment case with 60% analyst buy ratings and $98.75 consensus price target suggesting 9% upside. The stock offers dividend income with $0.72 quarterly payout and strong cash flow generation. Key risks include rising debt levels with debt-to-asset ratio increasing to 31.11% in 2025 and competitive pressures in medical technology sector. The combination of valuation discount to peers, consistent execution, and innovation pipeline supports positive medium-term outlook.